#Nyu download refworks trial#

Data were analyzed from July 2020 to May 2021.Р”В®xposures Presence or absence of acute infarct on index imaging. Univariable Cox regression models evaluated associations between the presence of an infarct on index imaging and subsequent ischemic stroke and evaluated whether the presence of infarct on index imaging modified the association of clopidogrel-aspirin with subsequent ischemic stroke risk.

#Nyu download refworks trial#

All POINT trial participants with information available on the presence or absence of acute infarct on index imaging were eligible for this study. In this post hoc analysis, patients were divided into 2 groups according to whether they had an acute infarct on index imaging. Objective To investigate whether the association of clopidogrel-aspirin with stroke recurrence in patients with minor stroke or high-risk transient ischemic attack (TIA) is modified by the presence of infarct on imaging attributed to the index event (index imaging) among patients enrolled in the POINT Trial.Р”Вesign, Setting, and Participants In the POINT randomized clinical trial, patients with high-risk TIA and minor ischemic stroke were enrolled at 269 sites in 10 countries in North America, Europe, Australia, and New Zealand from May 28, 2010, to December 19, 2017.

There may be specific patient groups who are more likely to benefit from this treatment. Importance In the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trial, acute treatment with clopidogrel-aspirin was associated with significantly reduced risk of recurrent stroke.